|
RPL23AP53 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.190100E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.107800E-02 |
| Normal-vs-Stage2 |
9.084900E-03 |
| Normal-vs-Stage3 |
8.45310000000543E-05 |
| Normal-vs-Stage4 |
2.559700E-03 |
| Stage1-vs-Stage2 |
1.469420E-01 |
| Stage1-vs-Stage3 |
1.157510E-03 |
| Stage1-vs-Stage4 |
6.041700E-02 |
| Stage2-vs-Stage3 |
5.257400E-01 |
| Stage2-vs-Stage4 |
8.908000E-01 |
| Stage3-vs-Stage4 |
5.835000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.780900E-04 |
| Normal-vs-AfricanAmerican |
1.338130E-02 |
| Normal-vs-Asian |
9.626200E-01 |
| Caucasian-vs-AfricanAmerican |
9.296600E-01 |
| Caucasian-vs-Asian |
2.192600E-01 |
| AfricanAmerican-vs-Asian |
1.896410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.398720E-03 |
| Normal-vs-Female |
2.917700E-03 |
| Male-vs-Female |
9.355600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.140200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.144100E-03 |
| Normal-vs-Age(61-80Yrs) |
4.797500E-04 |
| Normal-vs-Age(81-100Yrs) |
1.635930E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.524580E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.444100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.167700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.381820E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.732000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.962400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.390800E-01 |
| Normal-vs-Grade 2 |
4.618100E-02 |
| Normal-vs-Grade 3 |
3.031600E-04 |
| Normal-vs-Grade 4 |
2.16860000001873E-06 |
| Grade 1-vs-Grade 2 |
8.454500E-02 |
| Grade 1-vs-Grade 3 |
4.620300E-02 |
| Grade 1-vs-Grade 4 |
1.443660E-02 |
| Grade 2-vs-Grade 3 |
3.763600E-03 |
| Grade 2-vs-Grade 4 |
1.93993999999531E-05 |
| Grade 3-vs-Grade 4 |
6.221700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.259200E-03 |
| Normal-vs-ccB subtype |
1.490190E-02 |
| ccA subtype-vs-ccB subtype |
6.967200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.804700E-03 |
| Normal-vs-N1 |
7.109400E-01 |
| N0-vs-N1 |
6.155000E-01 |
|
|
